With both the Moderna and Johnson & Johnson vaccines nearing authorization for their COVID booster shots, what still needs to happen and what can you expect? Here's what we know so far.

Moderna's COVID-19 vaccine, which currently requires two doses and is said to be over 90 percent effective against the virus, will likely include a third shot made available later this year.

She says she does not recommend doing that. Moderna is also working on a vaccine that would combine a "COVID-19 variant booster + seasonal flu booster + RSV booster," all in a single dose.

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

COVID-19 vaccine maker Moderna will make a third booster shot for its two-dose vaccine available to Americans by the fall, CEO Stéphane Bancel said this week.

Moderna's submission for a second booster using the same formula comes just weeks after its chief medical officer, Dr. Paul Burton, told NBC News that an updated Covid vaccine would be needed in ...

COVID vaccine cocktails: A guide to mixing and matching Pfizer, Moderna, J&J booster shots On Oct. 21, the CDC OK'd booster doses from competing companies.

Moderna said it sold $5.9 billion worth of its coronavirus vaccine during the six-month period ending June 30th, for a total of 302 million doses. The company reported a net income of $2.8 billion ...

More than 69 million people in the United States have been fully vaccinated with Moderna’s COVID vaccine, but before the government recommends boosters for many of them — a decision that could ...

Another study suggests that getting either a Pfizer booster — which is 30 micrograms — or a Moderna booster following a shot similar to J&J are quite beneficial, Gandhi said.

Moderna's COVID-19 vaccine booster is half the dose of the initial shots used in its two-shot vaccination — 50 micrograms of mRNA versus 100 micrograms per each initial shot.

Moderna said Thursday it’s developing a booster shot that protects against COVID-19 and the seasonal flu in a single dose. “Our number one priority as a company right now is to bring to market ...